Five Prime Therapeutics Rings the NASDAQ Stock Market Opening Bell
Monday, September 19, 2016
Five Prime Therapeutics (Nasdaq: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, will visit the Nasdaq MarketSite in Times Square.
In honor of the occasion, Lewis T. “Rusty” Williams, Founder, President and CEO, will ring the Opening Bell.
Five Prime Therapeutics, Inc. discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. Five Prime's comprehensive discovery platform, which encompasses virtually every medically relevant extracellular protein, positions it to explore pathways in cancer, inflammation and their intersection in immuno-oncology, an area with significant therapeutic potential and a growing focus of the company's R&D activities. Five Prime has entered into strategic collaborations with leading global pharmaceutical companies and has promising product candidates in clinical and preclinical development. For more information, please visit www.fiveprime.com.